Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

NCT03595592 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Invasive Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Atezolizumab
PROCEDURE: Surgery

Sponsor

Fondazione Michelangelo

Collaborators

[object Object]